WallStreetZenWallStreetZen

NYSE: SYK
Stryker Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SYK past earnings growth

How has SYK's earnings growth performed historically?
Company
27.71%
Industry
476.75%
Market
117.28%
SYK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SYK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
SYK's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

SYK past revenue growth

How has SYK's revenue growth performed historically?
Company
10.61%
Industry
10.49%
Market
14.94%
SYK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SYK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SYK's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SYK earnings and revenue history

Current Revenue
$21.0B
Current Earnings
$3.4B
Current Profit Margin
16%
SYK's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

SYK Return on Equity

Current Company
18.4%
Current Industry
7.8%
Current Market
28.2%
SYK's Return on Equity (18.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SYK announces earnings.

SYK Return on Assets

Current Company
8.7%
Current Industry
6.2%
SYK is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SYK Return on Capital Employed

Current Company
12.07%
Current Industry
9.8%
SYK has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SYK vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SYK$20.96B$4.32B$3.36B+8.60%-1.24%
MDT$32.32B$8.88B$4.20B+1.13%-2.90%
BSX$14.71B$3.64B$1.77B+8.16%-1.59%
ABT$40.33B$10.41B$5.63B+5.59%+16.74%
EW$6.14B$1.81B$1.41B+9.96%+13.76%
View Top Medical Device Stocks

Stryker Earnings & Revenue FAQ

What were SYK's earnings last quarter?

On Invalid Date, Stryker (NYSE: SYK) reported Q1 2024 earnings per share (EPS) of $2.07, up 32.69% year over year. Total Stryker earnings for the quarter were $788.00 million. In the same quarter last year, Stryker's earnings per share (EPS) was $1.56.

If you're new to stock investing, here's how to buy Stryker stock.

What was SYK's earnings growth in the past year?

As of Q2 2024, Stryker's earnings has grown 27.71% year over year. This is 449.04 percentage points lower than the US Medical Devices industry earnings growth rate of 476.75%. Stryker's earnings in the past year totalled $3.36 billion.

What was SYK's revenue last quarter?

On Invalid Date, Stryker (NYSE: SYK) reported Q1 2024 revenue of $5.24 billion up 9.73% year over year. In the same quarter last year, Stryker's revenue was $4.78 billion.

What was SYK's revenue growth in the past year?

As of Q2 2024, Stryker's revenue has grown 10.61% year over year. This is 0.12 percentage points higher than the US Medical Devices industry revenue growth rate of 10.49%. Stryker's revenue in the past year totalled $20.96 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.